Do you want to visit the AmgenPro website and leave Amgen.nl?
You are now leaving the Amgen Netherlands website and will be redirected to AmgenPro – the portal designed specifically for healthcare professionals. This website is only available in Dutch. Healthcare professionals who are authorized to prescribe medication, can create an account using their BIG number and will then gain access to all available information.
By selecting the Yes option, leaving Amgen.nl option you understand that you are leaving the corporate page of Amgen nl and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen nl is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in nl. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
By selecting the Yes option, leaving Amgen.nl option you understand that you are leaving the corporate page of Amgen nl and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen nl is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in nl. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
When people are affected by illness, they deserve the best possible care. To improve the way care is delivered, Amgen works closely with healthcare providers and patients to create more customized solutions. This includes empowering patients—where possible and in consultation with their healthcare provider—to take a more active role in their treatment. For example, by teaching patients how to self-administer their medication.
We believe that by working together, we can deliver the best possible care for patients. This may involve shifting care from hospital to home or supporting patients to become more self-reliant. With over 20 years of experience in data-driven healthcare optimization, we collaborate with pharmacists, hospitals, and other healthcare organizations. By combining our knowledge and experience, we help enable sustainable healthcare solutions for patients.
Under the name AmgenCare, we offer a number of dedicated care programs tailored to specific conditions. These programs have been supporting patients for over 20 years, helping more than 50,000 people so far. Our care programs include home delivery of medication, administration and specialized care, comprehensive information and instructions to help patients manage their treatment independently (depending on the type of medication), at-home blood collection, access to an online patient support platform, and monitoring of treatment adherence and outcomes.
The AmgenCare cardiovascular program offers digital and physical services, helping (very) high-risk cardiovascular patients with their treatment, adherence and persistence to therapy. These services include home delivery of medication, administration instruction by an experienced nurse at the patient's home, and a digital patient portal.
The AmgenCare oncology program includes at-home delivery, instruction and administration of medication. Also additional information is available for each patient, depending on the treatment to be followed. The program is aimed at reducing the burden of treatment and the disease process as much as possible through personal guidance and its services.
The AmgenCare Hematology program focuses on home-based treatment and empowering ITP patients to become more self-reliant. Services include home delivery of medication, administration at home, and comprehensive administration instructions provided by an experienced nurse during a home visit.
